Population
rat platelet membranes
Design
Preclinical
Authors
Loading...
Supports irreversible ADP receptor modification by clopidogrel in rats; leaves open translation to human antiplatelet therapy.
Clopidogrel inhibits ADP-induced platelet aggregation by impairing the interaction of the ADP receptor with its G protein through irreversible modification.
Gachet et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: